PMV Pharmaceuticals Lands $30,000,000 Series A Financing

  • Feed Type
  • Date
    12/3/2014
  • Company Name
    PMV Pharmaceuticals
  • Mailing Address
    497 Seaport Court Redwood City, CA 94063 USA
  • Company Description
    PMV Pharmaceuticals is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus.
  • Website
    http://www.pmvpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The proceeds of this financing will support the advancement of the Company’s rapidly emerging pipeline of p53 focused therapeutics.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy